Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001677948 | SCV001894849 | benign | not provided | 2020-04-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001677948 | SCV002456056 | benign | not provided | 2025-01-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002421239 | SCV002729921 | likely benign | Inborn genetic diseases | 2018-01-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003975900 | SCV004789789 | benign | SMARCA2-related disorder | 2019-05-07 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |